source
- STAT+: Pharmalittle: We’re reading about rising drug shortages, GSK coughing up a trial loss, and moreThe number of active medication shortages in the U.S. rose to 227 in the second quarter of 2026STAT · 13d ago↗ source
- GSK culls cough program for drug at the heart of $2B Bellus bet after Phase 3 failCamlipixant, which GSK picked up in its $2 billion buyout of Bellus Health in April 2023, “is unlikely to transform patient care,” the pharma said.BioSpace · 13d ago↗ source
- Who can access testosterone hormone medication in the U.S.?Wildfire smoke health hazards, a new idea for treating Duchenne, and more health news from Morning RoundsSTAT · 13d ago↗ source